You are here

Africa

HHS Contracts with Mapp Biopharmaceutical to Develop Ebola Drug

                               

Work will accelerate drug development and testing

hhs.gov - News - Press Release - September 2, 2014

The development of a medication to treat illness from Ebola will be accelerated under a contract with the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR). This contract supports the government-wide response to the Ebola outbreak in West Africa.

ASPR’s Biomedical Advanced Research and Development Authority (BARDA) will provide funding as well as access to subject matter expertise and technical support for manufacturing, regulatory, and nonclinical activities through a $24.9 million, 18-month contract with Mapp Biopharmaceutical Inc., of San Diego, California. ASPR can extend the contract up to a total of $42.3 million.

Work under the contract supports the development and manufacturing of the medication ZMapp toward the goal of U.S. Food and Drug Administration approval.

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Another American Doctor Infected With Ebola in Liberia

       

Missionary Doctor Being Treated in Monrovia Hospital

wsj.com - by Betsy McKay - simusa.org - September 2, 2014

A third American missionary has been infected with Ebola while working in Liberia and is being treated in an isolation unit in the Monrovia hospital where he works.

The man, a doctor, was treating obstetrics patients, not Ebola patients. . .

. . . It isn't known how the doctor was infected, SIM USA said in a statement Tuesday.

(READ COMPLETE ARTICLE)

CLICK HERE - STATEMENT from SIM - SIM Missionary Doctor in Liberia Tests Positive for Ebola

 

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

CDC Fighting Ebola at Home and Abroad: Staff Deployed to W Africa, Enhanced Surveillance, Testing, and Guidance in US

cdc.gov - August 13, 2014

More than 50 CDC experts battling Ebola in Africa

Hundreds of public health professionals working 24/7 in support

The Centers for Disease Control and Prevention now has more than 50 disease detectives and other highly trained experts battling Ebola on the ground in West Africa – successfully deploying in less than two weeks the surge of help it promised within 30 days.

CDC’s Emergency Operations Center is also at its highest level of alert.  This means more than 350 CDC U.S. staff are working on logistics, communications, analytics, management, and other support functions to support the response 24/7.

“We are fulfilling our promise to the people of West Africa, Americans, and the world, that CDC would quickly ramp up its efforts to help bring the worst Ebola outbreak in history under control,” said CDC Director Tom Frieden, M.D., M.P.H.  “We know how to stop Ebola.  It won’t be easy or fast, but working together with our U.S. and international partners and country leadership, together we are doing it.”

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

U.S. Orders Departure of Eligible Family Members from Sierra Leone

Department of State SealPress Statement

Marie Harf
Deputy Department Spokesperson, Office of the Spokesperson
Washington, DC
August 14, 2014
 
At the recommendation of the U.S. Embassy in Sierra Leone, the State Department today ordered the departure from Freetown of all eligible family members (EFMs) not employed by post. The Embassy recommended this step out of an abundance of caution, following the determination by the Department’s Medical Office that there is a lack of options for routine health care services at major medical facilities due to the Ebola outbreak.

http://www.state.gov/r/pa/prs/ps/2014/230613.htm

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Ebola Virus Info - Twitter - @InfoEbola

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

CSPAN - House Foreign Affairs Subcommittee - Ebola Virus

c-span.org - August 7, 2014

The House Foreign Affairs Subcommittee on Africa, Global Health, Global Human Rights, and International Organizations held a hearing titled, “Combating the Ebola Threat.”

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

ZMapp - Information Sheet

                                                        

ZMapp TM is the result of a collaboration between Mapp Biopharmaceutical Inc. and LeafBio (San Diego, CA), Defyrus Inc. (Toronto, Canada), the U.S. government and the Public Health Agency of Canada (PHAC).

ZMapp TM is composed of three “humanized” monoclonal antibodies manufactured in plants, specifically Nicotiana.  It is an optimized cocktail combining the best components of MB-­‐003 (Mapp) and ZMAb (Defyrus/PHAC).

ZMapp TM was first identified as a drug candidate in January 2014 and has not yet been evaluated for safety in humans.  As such very little of the drug is currently available.  

Any decision to use an experimental drug in a patient would be a decision made by the treating physician under the regulatory guidelines of the FDA.

Mapp and its partners are cooperating with appropriate government agencies to increase production as quickly as possible.

CLICK HERE - ZMapp - Information Sheet (1 page .PDF file)

http://www.mappbio.com/

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Africa
howdy folks